Results 241 to 250 of about 93,225 (309)

Comedications Associated with Immune‐Related Adverse Events from Immune‐Checkpoint Inhibitors

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 3, Page 593-599, September 2025.
Immune‐checkpoint inhibitors (ICI) have revolutionized cancer treatment but are responsible for various immune‐related adverse events (irAE). The impact of non‐anticancer medications (comedications) on irAE occurrence remains largely unexplored. The objective of this study was to assess comedications associated with an increased reporting of irAE with ...
Léonard Laurent   +10 more
wiley   +1 more source

Liver homotransplantation [PDF]

open access: yes, 1986
Iwatsuki, S, Shaw, BW, Starzl, TE
core  

The Efficacy and Safety of Seladelpar for Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis

open access: yesJGH Open, Volume 9, Issue 9, September 2025.
ABSTRACT Background and Objective Seladelpar is an oral, once‐daily medication that improves cholestasis through its selective peroxisome proliferator‐activated receptor (PPAR‐δ) agonism. It shows promising efficacy in treating primary biliary cholangitis (PBC) patients.
Mohamed Abuelazm   +7 more
wiley   +1 more source

Application of Self‐Expandable Metal Stent in Dogs and Cats for the Management of Extrahepatic Biliary Obstruction: 13 Cases (2021–2024)

open access: yesVeterinary Medicine and Science, Volume 11, Issue 5, September 2025.
Extrahepatic biliary obstruction in dogs and cats is life‐threatening. Biliary self‐expandable metal stents (SEMS) provide a minimally invasive treatment, effectively relieving the obstruction with fewer complications. SEMS offers the potential for long‐term or permanent relief, significantly improving outcomes and quality of life in affected animals ...
Suh Hyun Chai   +3 more
wiley   +1 more source

Liver retransplantation in adults: Overall results and determinant factors affecting the outcome [PDF]

open access: yes, 1991
Gordon, RD   +5 more
core  

Home - About - Disclaimer - Privacy